{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T16:34:01Z","timestamp":1787070841492,"version":"build-2736575974"},"reference-count":21,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2021,4]]},"abstract":"<jats:sec>\n                    <jats:title>Purpose:<\/jats:title>\n                    <jats:p>The present study evaluates procedure-associated pain and side effects in the gastrointestinal\u2013genitourinary system in patients with early-stage prostate cancer who were treated with image-guided radiotherapy (IGRT), accompanied by an ultrasound-guided transrectal implantation of fiducial markers, without local anesthesia.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Materials and Methods:<\/jats:title>\n                    <jats:p>A total of 46 patients who referred to our clinics between 2012 and 2017 with a diagnosis of early-stage prostate cancer were included in the study. Before undergoing radiotherapy, all patients were implanted with three intraprostatic fiducial markers through the ultrasound-guided transrectal approach without local anesthesia. The patients underwent radiotherapy after the clinical target volumes were established, in accordance with the respective risk groups, and localization of the markers was confirmed before each therapy session. The levels of procedure-associated pain and side effects were graded immediately after the procedure through the use of a patient-based scoring system.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>The faces pain scale \u2013 revised version was used for the measurement of the severity of procedure-associated pain. Of the total study sample, the facial expressions of 38 patients (35%) corresponded to level 0 in the study, seven (15%) to level 2, and a single patient (2%) to level 4. None of the facial expressions of the patients corresponded to levels 6, 8, or 10. The evaluation of procedure-related genitourinary and gastrointestinal system side effects indicated that nine patients (20%) experienced side effects, while no side effects were reported in 37 patients (80%). The reported side effects included rectal bleeding in two patients (4%), dysuria in three patients (6%), hematuria in five patients (11%), and frequent urination in five patients (11%). None of the patients experienced fever or hematospermia. All side effects were reported by the respondents as \u201ca little,\u201d while only one patient answered positively to the question on the frequency of urination. Among the patients who answered \u201cyes\u201d and \u201ca little\u201d to the questions evaluating genitourinary and gastrointestinal system side effects, the severity of these events was reported as Grade 1, corresponding to mild adverse, in only 9 (20%) patients. None of the patients experienced a Grade 2 or higher severe adverse event. In the comparison of the severity of pain of the patients during the fiducial marker procedure without local anesthesia with the severity of pain during the biopsy, 24 patients (80%) reported \u201clower\u201d levels of pain, while five patients (20%) reported \u201cequal\u201d levels of pain. None of the patients stated that they had experienced \u201cmore\u201d pain.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>IGRT accompanied by an ultrasound-guided implantation of fiducial markers without local anesthesia can be considered a safe method, given the associated acceptable levels of pain, low side effect profiles, and high prostate-specific antigen control rates.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/jcrt.jcrt_281_18","type":"journal-article","created":{"date-parts":[[2021,6,18]],"date-time":"2021-06-18T03:13:21Z","timestamp":1623986001000},"page":"353-357","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":4,"title":["Ultrasound-guided transrectal implantation of fiducial markers for image-guided radiotherapy of prostate cancer without local anesthesia"],"prefix":"10.4103","volume":"17","author":[{"given":"Cenk Ahmet","family":"Sen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-8-20241021","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1016\/S0360-3016(02)02829-8","article-title":"Prostate cancer radiation dose response: Results of the M. D. Anderson phase III randomized trial","volume":"53","author":"Pollack","year":"2002","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R2-8-20241021","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1001\/jama.294.10.1233","article-title":"Comparison of conventional-dose vs. high-dose conformal radiation therapy in clinically localized adenocarcinoma of the prostate: A randomized controlled trial","volume":"294","author":"Zietman","year":"2005","journal-title":"JAMA"},{"key":"R3-8-20241021","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1016\/j.ijrobp.2004.07.715","article-title":"Acute and late complications after radiotherapy for prostate cancer: Results of a multicenter randomized trial comparing 68 Gy to 78 Gy","volume":"61","author":"Peeters","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R4-8-20241021","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1016\/S0022-5347(05)65855-7","article-title":"High dose radiation delivered by intensity modulated conformal radiotherapy improves the outcome of localized prostate cancer","volume":"166","author":"Zelefsky","year":"2001","journal-title":"J Urol"},{"key":"R5-8-20241021","doi-asserted-by":"crossref","first-page":"3904","DOI":"10.1200\/JCO.2000.18.23.3904","article-title":"Preliminary results of a randomized radiotherapy dose-escalation study comparing 70 Gy with 78 Gy for prostate cancer","volume":"18","author":"Pollack","year":"2000","journal-title":"J Clin Oncol"},{"key":"R6-8-20241021","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S0090-4295(99)00380-5","article-title":"Importance of high radiation doses (72 Gy or greater) in the treatment of stage T1-T3 adenocarcinoma of the prostate","volume":"55","author":"Lyons","year":"2000","journal-title":"Urology"},{"key":"R7-8-20241021","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/S0360-3016(00)00700-8","article-title":"Complications from radiotherapy dose escalation in prostate cancer: Preliminary results of a randomized trial","volume":"48","author":"Storey","year":"2000","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R8-8-20241021","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/S0167-8140(99)00100-0","article-title":"Clinical experience with intensity modulated radiation therapy (IMRT) in prostate cancer","volume":"55","author":"Zelefsky","year":"2000","journal-title":"Radiother Oncol"},{"key":"R9-8-20241021","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1186\/1748-717X-6-145","article-title":"Acute toxicity in prostate cancer patients treated with and without image-guided radiotherapy","volume":"6","author":"Gill","year":"2011","journal-title":"Radiat Oncol"},{"key":"R10-8-20241021","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/1748-717X-9-44","article-title":"Improvement in toxicity in high risk prostate cancer patients treated with image-guided intensity-modulated radiotherapy compared to 3D conformal radiotherapy without daily image guidance","volume":"9","author":"Sveistrup","year":"2014","journal-title":"Radiat Oncol"},{"key":"R11-8-20241021","doi-asserted-by":"crossref","first-page":"2740","DOI":"10.1200\/JCO.2000.18.14.2740","article-title":"Survival advantage from higher-dose radiation therapy for clinically localized prostate cancer treated on the radiation therapy oncology group trials","volume":"18","author":"Valicenti","year":"2000","journal-title":"J Clin Oncol"},{"key":"R12-8-20241021","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1186\/1748-717X-7-56","article-title":"Analysis of inter-fraction setup errors and organ motion by daily kilovoltage cone beam computed tomography in intensity modulated radiotherapy of prostate cancer","volume":"7","author":"Palombarini","year":"2012","journal-title":"Radiat Oncol"},{"key":"R13-8-20241021","doi-asserted-by":"crossref","first-page":"1808","DOI":"10.1093\/jnci\/djr493","article-title":"Use of patient-reported outcomes to improve the predictive accuracy of clinician-reported adverse events","volume":"103","author":"Basch","year":"2011","journal-title":"J Natl Cancer Inst"},{"key":"R14-8-20241021","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.radonc.2010.05.011","article-title":"Development of a patient-reported questionnaire for collecting toxicity data following prostate brachytherapy","volume":"97","author":"Farnell","year":"2010","journal-title":"Radiother Oncol"},{"key":"R15-8-20241021","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/S0304-3959(01)00314-1","article-title":"The faces pain scale-revised: Toward a common metric in pediatric pain measurement","volume":"93","author":"Hicks","year":"2001","journal-title":"Pain"},{"key":"R16-8-20241021","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.ijnurstu.2006.01.001","article-title":"Reliability and validity of the faces pain scale with older adults","volume":"43","author":"Kim","year":"2006","journal-title":"Int J Nurs Stud"},{"key":"R17-8-20241021","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.urology.2007.10.011","article-title":"Technique for implantation of fiducial markers in the prostate","volume":"71","author":"Shinohara","year":"2008","journal-title":"Urology"},{"key":"R18-8-20241021","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1016\/j.urology.2008.10.071","article-title":"Technique of outpatient placement of intraprostatic fiducial markers before external beam radiotherapy","volume":"73","author":"Linden","year":"2009","journal-title":"Urology"},{"key":"R19-8-20241021","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1016\/j.ijrobp.2005.02.022","article-title":"Prostate position relative to pelvic bony anatomy based on intraprostatic gold markers and electronic portal imaging","volume":"63","author":"Schallenkamp","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R20-8-20241021","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.radonc.2006.03.002","article-title":"Clinical application of a repositioning scheme, using gold markers and electronic portal imaging","volume":"79","author":"Van den Heuvel","year":"2006","journal-title":"Radiother Oncol"},{"key":"R21-8-20241021","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/j.ijrobp.2006.01.008","article-title":"Comparison of ultrasound and implanted seed marker prostate localization methods: Implications for image-guided radiotherapy","volume":"65","author":"Scarbrough","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"}],"container-title":["Journal of Cancer Research and Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/jcrt.JCRT_281_18","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T15:37:30Z","timestamp":1787067450000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/jcrt.JCRT_281_18"}},"subtitle":["Patient-reported gastrointestinal\u2013genitourinary system complications and pain"],"short-title":[],"issued":{"date-parts":[[2021,4]]},"references-count":21,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.4103\/jcrt.jcrt_281_18","relation":{},"ISSN":["0973-1482"],"issn-type":[{"value":"0973-1482","type":"print"}],"subject":[],"published":{"date-parts":[[2021,4]]}}}